Xcout IntelOrgenesis Inc. competitors & alternatives
The 12 closest competitors and alternatives to Orgenesis Inc. among biotech companies — ranked by similarity to what Orgenesis Inc. actually does, not by market-cap band.
Subscribe to see Orgenesis Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Orgenesis Inc.
Orgenesis Inc. is a public biotechnology company founded in 2012. It has its primary headquarters located in Germantown, Maryland, United States.
Orgenesis Inc. at a glance
Orgenesis Inc. is a biotech company headquartered in United States. It has raised at least $33.9M across the 6 funding rounds on record. Its most recent funding round raised $2.3M in March 2024. Xcout tracks 3 named people at Orgenesis Inc., including Vered Caplan (Chief Executive Officer of Orgenesis Inc.).
Orgenesis Inc. leadership
- Vered CaplanChief Executive Officer of Orgenesis Inc.
- Victor MillerChief Financial Officer of Orgenesis
- Heiko von der LeyenMedical Director
Orgenesis Inc. funding rounds
At least $33.9M raised across the 6 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.3M | — | |
| Seed | $1M | — | |
| SEC Form D filing | $14.8M | — | |
| SEC Form D filing | $9.2M | — | |
| SEC Form D filing | $1.2M | — | |
| SEC Form D filing | $5.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Orgenesis Inc. competitors
Ranked by semantic similarity — how close each company is to Orgenesis Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings designed to preserve vital cells, growth factors, and ECM proteins found in natural tissue. Apligraf is a bioengineered living cell therapy that releases a range of healing cytokines and growth factors, while Dermagraft is another bioengineered solution that generates human collagen, ECM, proteins, and cytokines. NuShield provides a wound covering incorporating both amnion and chorion membranes to maintain a spongy intermediate layer. PuraPly acts as an antimicrobial barrier, allowing for flexibility and effective fluid drainage. For the surgical and sports medicine sectors, the company provides products such as NuCel, a dehydrated placental tissue designed for surgical application to promote natural tissue regeneration. ReNu is a cryopreserved suspension aimed at aiding soft tissue recovery. Additionally, FiberOS and OCMP serve as bone void fillers, primarily utilized in orthopedic and neurosurgical procedures. Looking ahead, Organogenesis's product pipeline features PuraPly XT and PuraPly MZ, which are being developed for treating chronic, acute, and open wounds. PuraForce is a bioengineered porcine collagen surgical matrix intended for soft tissue reinforcement. TransCyte, another bioengineered tissue, is in development for addressing partial thickness burns. Organogenesis distributes its offerings to a diverse client base, including hospitals, specialized wound care centers, government institutions, ambulatory surgical centers, and physician offices, leveraging both its direct sales team and independent agencies. Established in 1985, the company maintains its headquarters in Canton, Massachusetts.
Similar biotech company
Deka Biosciences, Inc. is an early-stage biotechnology holding company located in Germantown, Maryland, focused on developing and delivering life-changing medicines for cancer patients.
Biotechnology
NX PharmaGen Inc. is a biotechnology company headquartered in Louisville, Kentucky, focused on groundbreaking scientific technologies and cell processing.
Biotechnology
Oragenics, Inc. is a biotechnology development-stage company incorporated in Florida in 1996 and headquartered in Lakewood Ranch, Florida. It is dedicated to fighting infectious diseases, including coronaviruses and multidrug-resistant pathogens.
Biotechnology
FibroGenesis is a U.S. biotechnology company focused on developing therapies for fibrosis and related fibrotic diseases. Its work is intended to serve patients with serious disorders in which excessive scar-tissue formation damages organs or tissues.
Similar biotech company
Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and computational modeling to engineer complex gene expression programs; mbIL15, a gene designed to enhance immune cell function; the non-viral Sleeping Beauty transposon/transposase system for genetic modification; and AttSite recombinases, tools for precise DNA recombination. Furthermore, Precigen utilizes its AdenoVerse platform, a library of engineered adenovectors for gene delivery and immunotherapy applications, alongside L. lactis, a food-grade bacterium. The company also provides RheoSwitch, an inducible gene switch system offering quantitative, dose-proportionate control over target protein expression's timing and amount; kill switches, designed to selectively eliminate cell therapies within the body; tissue-specific promoters for targeted gene expression; the UltraCAR-T platform for cancer treatment; and the ActoBiotics platform, which employs genetically modified bacteria to deliver proteins and peptides directly to mucosal sites. Precigen maintains strategic collaboration and license agreements with Alaunos Therapeutics, Inc., Ares Trading S.A., Oragenics, Inc., Castle Creek Biosciences, Inc., and Intrexon Energy Partners I and II, LLC. Established in 1998, Precigen, Inc., previously known as Intrexon Corporation, adopted its current name in January 2020 and is headquartered in Germantown, Maryland.
Biotechnology
Precise Bio, Inc. is a clinical-stage regenerative medicine company that grows live organs for transplant using 3D bio-printing technology.
Biotechnology
CiVi Biopharma, Inc. is a privately held biopharmaceutical company headquartered in Chevy Chase, Maryland, founded in 2016 to advance specialized clinical therapeutics.
Biotechnology
NeXtGen Biologics, Inc. is a medical equipment manufacturing and biotechnology company located in Alachua, Florida, specializing in advanced regenerative medicine.
Biotechnology
Arcellx, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to developing innovative immunotherapies and cell therapies for cancer patients.
Biotechnology
miRecule, Inc. is a biotechnology company headquartered in Gaithersburg, Maryland, focused on developing RNA therapeutics.
Biotechnology
Orionis Biosciences is a biotechnology research company with its US headquarters located in Waltham, Massachusetts, specializing in innovative life sciences and drug discovery services.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Orgenesis Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Orgenesis Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →